Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.

Clinical trial NCT05981079 · UNKNOWN

Trial details

NCT number: NCT05981079
Sponsor: Shandong University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Late-Onset Neonatal Sepsis

Start date: 2023-07-31
Primary completion: 2024-12-31
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.